Oral anticoagulation to prevent thrombosis recurrence in polycythemia vera and essential thrombocythemiaArturo Pereira, Juan Carlos Hernández‐Boluda, Eduardo Arellano‐Rodrigo et al.|Annals of Hematology|2015Cited by 54
A novel deep targeted sequencing method for minimal residual disease monitoring in acute myeloid leukemiaEsther Onecha, Rosa Ayala, José Antonio García Vela et al.|Haematologica|2018Cited by 51
Real‐world analysis of main clinical outcomes in patients with polycythemia vera treated with ruxolitinib or best available therapy after developing resistance/intolerance to hydroxyureaAlberto Álvarez‐Larrán, Marta Garrote, Francisca Ferrer‐Marín et al.|Cancer|2022Cited by 32
Predictors of thrombosis and bleeding in 1613 myelofibrosis patients from the Spanish Registry of MyelofibrosisJuan Carlos Hernández‐Boluda, Irene Pastor‐Galán, Eduardo Arellano‐Rodrigo et al.|British Journal of Haematology|2022Cited by 16
Improving the prediction of acute myeloid leukaemia outcomes by complementing mutational profiling with <i>ex vivo</i> chemosensitivityEsther Onecha, Rosa Ayala, Yanira Ruiz‐Heredia et al.|British Journal of Haematology|2020Cited by 14